This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Arcadia Biosciences, Inc.. Active years: 2011-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2012
Title: Eric Rey: Innovator in Safflower Biotechnology
Introduction
Eric Rey is a notable inventor based in Berkeley, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of safflower plants with enhanced nutritional properties. With a total of 2 patents, Rey's work focuses on improving the production of gamma-linolenic acid (GLA) in safflower seeds.
Latest Patents
One of Eric Rey's latest patents involves the creation of safflower plants that produce elevated levels of gamma-linolenic acid. This invention utilizes nucleic acid sequences and constructs that encode fatty acid desaturase sequences. By generating transgenic safflower plants, Rey has enabled the production of high levels of GLA in safflower seeds. The oils derived from these seeds have potential applications in treating various diseases, including nervous system disorders, inflammatory conditions, cancer, and cardiovascular disorders.
Career Highlights
Eric Rey is currently associated with Arcadia Biosciences, Inc., where he continues to advance his research in plant biotechnology. His innovative approaches have positioned him as a key figure in the development of transgenic crops that offer health benefits.
Collaborations
Throughout his career, Rey has collaborated with notable colleagues, including Vic C Knauf and Christine K Shewmaker. These partnerships have contributed to the success of his research and the advancement of biotechnology in agriculture.
Conclusion
Eric Rey's work in safflower biotechnology exemplifies the impact of innovation in agriculture. His patents and research efforts are paving the way for healthier crops and potential treatments for various health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
